Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
2 hedge funds and large institutions have $90K invested in Bio Green Med Solution Inc Preferred Stock in 2018 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0.47% more ownership
Funds ownership: 4.07% → 4.53% (+0.47%)
0% more funds holding
Funds holding: 2 → 2 (0)
6% less capital invested
Capital invested by funds: $96K → $90K (-$6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$9.64K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BBA
1
Baker Bros. Advisors
New York
| $77K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $13K | +$9.64K | +1,593 | +279% |
|
BGMSP Hedge Fund Activity: Q1 2018 in Review
2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q1 2018, worth a combined $90K — down 6.3% from $96K a quarter earlier.
Fund positioning in BGMSP was balanced in Q1 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $9.64K.
- 2 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q1 2018, unchanged from Q4 2017.
- Funds reported $90K of Bio Green Med Solution Inc Preferred Stock stock for Q1 2018, down 6.3% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q1 2018 and 0 closed out.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q1 2018 was UBS Group, an estimated $9.64K added.
Based on aggregated 13F filings for Q1 2018.